Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Exelixis
Related studies linked through entity extraction aliases.
Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
- Status
- COMPLETED
- Phase
- PHASE1
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cabozantinib in High Grade Neuroendocrine Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment
- Status
- TERMINATED
- Phase
- PHASE3
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
- Status
- RECRUITING
- Phase
- PHASE2
Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cabozantinib and Nivolumab for Carcinoid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2